Historic Consolidated Net Income for Nuvation Bio (NUVB) over the last 5 years, with Jun 2025 value amounting to -$59.0 million.
- Nuvation Bio's Consolidated Net Income rose 87.24% to -$59.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$202.9 million, marking a year-over-year increase of 60.27%. This contributed to the annual value of -$567.9 million for FY2024, which is 649.24% down from last year.
- As of Q2 2025, Nuvation Bio's Consolidated Net Income stood at -$59.0 million, which was down 10.84% from -$53.2 million recorded in Q1 2025.
- In the past 5 years, Nuvation Bio's Consolidated Net Income registered a high of -$13.8 million during Q4 2023, and its lowest value of -$462.5 million during Q2 2024.
- Over the past 3 years, Nuvation Bio's median Consolidated Net Income value was -$31.5 million (recorded in 2023), while the average stood at -$75.6 million.
- As far as peak fluctuations go, Nuvation Bio's Consolidated Net Income crashed by 2,140.76% in 2024, and later surged by 87.24% in 2025.
- Quarterly analysis of 5 years shows Nuvation Bio's Consolidated Net Income stood at -$25.1 million in 2021, then increased by 17.06% to -$20.8 million in 2022, then surged by 33.86% to -$13.8 million in 2023, then plummeted by 258.63% to -$49.4 million in 2024, then skyrocketed by 87.24% to -$59.0 million in 2025.
- Its last three reported values are -$59.0 million in Q2 2025, -$53.2 million for Q1 2025, and -$49.4 million during Q4 2024.
